Epstein Secrets

asted revenues and expenses highlighted above and was detanitheil hi he reawnable bawd on guideline company indications. According to management. the Company\ , term EBIT margin is expected to be higher than the average and median of the guideline company indications as a result of the anticipated increas

ear holding period. Therefore, hereafter, references to the FMV study refer only to those securities with a two-year holding period. CONFIDENTIAL i wras LLC 74 EFTA00307469 WTAS ALIPHCOM - COMMON EQUITY VALUATION REPORT As of June 20, 2011 • Market Price Volatility. Companies with greater volatilit

asted revenues and expenses highlighted above and was detanitheil hi he reawnable bawd on guideline company indications. According to management. the Company\ , term EBIT margin is expected to be higher than the average and median of the guideline company indications as a result of the anticipated increas

ear holding period. Therefore, hereafter, references to the FMV study refer only to those securities with a two-year holding period. CONFIDENTIAL i wras LLC 74 EFTA00307368 WTAS ALIPHCOM - COMMON EQUITY VALUATION REPORT As of June 20, 2011 • Market Price Volatility. Companies with greater volatilit

asted revenues and expenses highlighted above and was detanitheil hi he reawnable bawd on guideline company indications. According to management. the Company\ , term EBIT margin is expected to be higher than the average and median of the guideline company indications as a result of the anticipated increas

ear holding period. Therefore, hereafter, references to the FMV study refer only to those securities with a two-year holding period. CONFIDENTIAL i wras LLC 74 EFTA00307267 WTAS ALIPHCOM - COMMON EQUITY VALUATION REPORT As of June 20, 2011 • Market Price Volatility. Companies with greater volatilit